75 related articles for article (PubMed ID: 7527635)
1. [Interaction of substance P receptor from rat brain with antibodies to its synthetic fragments and to substance P].
Kasheverov IE; Golovnina TA; Iarov AV; Utkin IuN; Tsetlin VI
Bioorg Khim; 1994 Jul; 20(7):720-30. PubMed ID: 7527635
[TBL] [Abstract][Full Text] [Related]
2. Antipeptide antibodies that recognize a lymphocyte substance P receptor.
Pascual DW; Blalock JE; Bost KL
J Immunol; 1989 Dec; 143(11):3697-702. PubMed ID: 2479686
[TBL] [Abstract][Full Text] [Related]
3. Anti-peptide antibodies recognize anti-substance P antibodies in an idiotypic fashion.
Pascual DW; Bost KL
Pept Res; 1989; 2(3):207-12. PubMed ID: 2485208
[TBL] [Abstract][Full Text] [Related]
4. Point mutation increases a form of the NK1 receptor with high affinity for neurokinin A and B and septide.
Ciucci A; Palma C; Manzini S; Werge TM
Br J Pharmacol; 1998 Sep; 125(2):393-401. PubMed ID: 9786514
[TBL] [Abstract][Full Text] [Related]
5. Systematic study of substance P analogs. I. Evaluation of peptides synthesized by the multipin method for quantitative receptor binding assay.
Wang JX; Bray AM; Dipasquale AJ; Maeji NJ; Geysen HM
Int J Pept Protein Res; 1993 Oct; 42(4):384-91. PubMed ID: 7503963
[TBL] [Abstract][Full Text] [Related]
6. Chemical cross-linking of the substance P (NK-1) receptor to the alpha subunits of the G proteins Gq and G11.
Macdonald SG; Dumas JJ; Boyd ND
Biochemistry; 1996 Mar; 35(9):2909-16. PubMed ID: 8608128
[TBL] [Abstract][Full Text] [Related]
7. Development of polyclonal anti-D2 dopamine receptor antibodies using sequence-specific peptides.
Boundy VA; Luedtke RR; Artymyshyn RP; Filtz TM; Molinoff PB
Mol Pharmacol; 1993 May; 43(5):666-76. PubMed ID: 8502224
[TBL] [Abstract][Full Text] [Related]
8. Recognition of neurokinin 1 receptor (NK1-R): an antibody to a peptide sequence from the third extracellular region binds to brain NK1-R.
van Ginkel FW; Pascual DW
J Neuroimmunol; 1996 Jun; 67(1):49-58. PubMed ID: 8707930
[TBL] [Abstract][Full Text] [Related]
9. The N-terminal domain of substance P is required for complete homologous desensitization but not phosphorylation of the rat neurokinin-1 receptor.
Vigna SR
Neuropeptides; 2001 Feb; 35(1):24-31. PubMed ID: 11346307
[TBL] [Abstract][Full Text] [Related]
10. [A new immunochemical method for detecting substance P receptors based on the biotin-streptavidin system].
Golovnina TA; Kasheverov IE; Plaksin DIu; Iakunina NB; Kovalenko VA; Utkin IuN; Tsetlin VI
Bioorg Khim; 1992 Jul; 18(7):932-41. PubMed ID: 1280142
[TBL] [Abstract][Full Text] [Related]
11. Presence of NK1 receptors on a mucosal-like mast cell line, RBL-2H3 cells.
Cooke HJ; Fox P; Alferes L; Fox CC; Wolfe SA
Can J Physiol Pharmacol; 1998 Feb; 76(2):188-93. PubMed ID: 9635159
[TBL] [Abstract][Full Text] [Related]
12. Regulation of the responses to gonadotropin-releasing hormone, muscarine and substance P in sympathetic neurons by changes in cellular constituents and intracellular application of peptide fragments of the substance P receptor.
Simmons MA; Schneider CR; Krause JE
J Pharmacol Exp Ther; 1994 Nov; 271(2):581-9. PubMed ID: 7525938
[TBL] [Abstract][Full Text] [Related]
13. Spatial association of prolyl oligopeptidase, inositol 1,4,5-triphosphate type 1 receptor, substance P and its neurokinin-1 receptor in the rat brain: an immunohistochemical colocalization study.
Myöhänen TT; Venäläinen JI; Garcia-Horsman JA; Männistö PT
Neuroscience; 2008 Jun; 153(4):1177-89. PubMed ID: 18455882
[TBL] [Abstract][Full Text] [Related]
14. p-(4-Hydroxybenzoyl)phenylalanine: a photoreactive amino acid analog amenable to radioiodination for elucidation of peptide-protein interaction. Application to substance P receptor.
Wilson CJ; Husain SS; Stimson ER; Dangott LJ; Miller KW; Maggio JE
Biochemistry; 1997 Apr; 36(15):4542-51. PubMed ID: 9109663
[TBL] [Abstract][Full Text] [Related]
15. High affinity binding sites for [3H]substance P in urinary bladders of cats with interstitial cystitis.
Buffington CA; Wolfe SA
J Urol; 1998 Aug; 160(2):605-11. PubMed ID: 9679937
[TBL] [Abstract][Full Text] [Related]
16. Purification of the 33,000-dalton ligand binding-protein constituent of the lymphoblast substance P receptor.
McGillis JP; Organist ML; Scriven KH; Payan DG
J Neurosci Res; 1987; 18(1):190-4. PubMed ID: 2824800
[TBL] [Abstract][Full Text] [Related]
17. Homophilic anchorage of brain-hexokinase to mitochondria-porins revealed by specific-peptide antibody cross recognition.
Oudard S; Miccoli L; Beurdeley-Thomas A; Dutrillaux B; Poupon MF
Bull Cancer; 2004 Jun; 91(6):E184-200. PubMed ID: 15562563
[TBL] [Abstract][Full Text] [Related]
18. Photoaffinity labeling of rat pancreatic cholecystokinin type A receptor antagonist binding sites demonstrates the presence of a truncated cholecystokinin type A receptor.
Poirot SS; Escrieut C; Dufresne M; Martinez J; Bouisson M; Vaysse N; Fourmy D
Mol Pharmacol; 1994 Apr; 45(4):599-607. PubMed ID: 8183238
[TBL] [Abstract][Full Text] [Related]
19. Specific binding of a 125I-labeled substance P analog to rat submaxillary gland.
Bahouth SW; Stewart JM; Musacchio JM
J Pharmacol Exp Ther; 1984 Jul; 230(1):116-23. PubMed ID: 6205134
[TBL] [Abstract][Full Text] [Related]
20. Comparative, general pharmacology of SDZ NKT 343, a novel, selective NK1 receptor antagonist.
Walpole CS; Brown MC; James IF; Campbell EA; McIntyre P; Docherty R; Ko S; Hedley L; Ewan S; Buchheit KH; Urban LA
Br J Pharmacol; 1998 May; 124(1):83-92. PubMed ID: 9630347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
